CAPR - Capricor Therapeutics EPS beats by $0.21 beats on revenue August, 06 2019 04:15 PM Capricor Therapeutics Inc. Capricor Therapeutics (NASDAQ:CAPR): Q2 GAAP EPS of -$0.59 beats by $0.21.More news on: Capricor Therapeutics, Inc., Earnings news and commentary, Healthcare stocks news, , Read more ...